Skip to search.
 FTSE 100 Down 3.15%

Becton, Dickinson and Company (BDX)

-NYSE
166.71 Down 5.48(3.18%) 24 Jun 21:01
|After Hours: : 166.68 Down 0.03 (0.02%) 24 Jun 21:55
Prev Close:172.19
Open:168.90
Bid:158.16 x 100
Ask:170.99 x 200
1y Target Est:176.31
Beta:1.00838
Earnings Date:4 Aug - 8 Aug (Est.)
Day's Range:166.25 - 169.73
52wk Range:128.87 - 172.20
Volume:1,464,129
Avg Vol (3m):926,852
Market Cap:35.38b
P/E (ttm):44.56
EPS (ttm):3.74
Div & Yield:2.64 (1.55%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BDX at this time.

Comparison

Symbol% ChgMkt Cap
BDXDown 3.18%35.38b
BAXDown 4.59%24.22b
ABTDown 4.34%55.70b

Key Statistics

Forward P/E (1 yr):17.59
P/S (ttm):2.99
Ex-Dividend Date:07-Jun-16

Analysts

Annual EPS Est (Sep-16) :8.57
Quarterly EPS Est (Jun-16) :2.21
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback